ELVN

NASDAQStock

Enliven Therapeutics, Inc.

$29.36-1.34 (-4.36%)

52-Week Range

$14.91

$30.70

Key Stats

Market Cap

1.7B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.06

Volume

540.5K

Avg Volume

742.4K

Performance

+2.86%

+67.79%

+55.73%

YTD

+85.39%

+41.99%

+29.19%

+21.31%

Price Chart

ETF Exposure

ELVN is held by 59 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	14	$418	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	10	$316	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	5	$140	$9.5M	0.12%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	459	$13K	$1.43B	0.09%
AVUS	Avantis U.S. Equity ETF	0.00%	1,126	$34K	$11.08B	0.15%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	3	$99	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	11	$328	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	18	$558	$81.7M	0.11%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.00%	153	$5K	$1.90B	0.26%

PreviousPage 2 of 2

About ELVN ETF Exposure

Enliven Therapeutics, Inc. (ELVN) is held by 59 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.7B, ELVN is a widely held institutional stock. The stock currently trades at $29.36. Investors can gain exposure to ELVN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ELVN, sorted by portfolio weight.